logo
Plus   Neg
Share
Email

DuPont Outlines Growth Strategy For Seed Business - Quick Facts

At the Eighteenth Annual Goldman Sachs Agribusiness Conference, Chemicals giant DuPont's leader Paul Schickler outlined growth drivers for the seed business, highlighting opportunities in key global agricultural markets and the recent launch of the Encirca(SM) services platform for U.S. growers. He said in a statement, "With an expected increase in population, urbanization and a rapidly emerging middle-class, we must become more productive on our existing land base." This would require science-based, sustainable solutions for the farmer and food company customers.

Over the next five years, the company expects nearly half of its growth in the Agriculture division to come from outside of North America focused mainly in the key markets of Latin America, Eastern Europe, India and China.

The global seed pipeline reinforces an integrated approach to product development and highlights agricultural solutions via. differential breeding, plant protection traits, corn agronomic traits, soybean output traits and hybridization systems. These solutions build on the recent product success of Optimum AQUAmax corn hybrids and Optimum AcreMax corn products validated by last year's gain of more than one point in North America corn market share, according to the company.

With respect to the whole-farm decision services, "Our approach to whole-farm decision services is different," said Schickler. "We are offering growers tailored services - no matter the brand - and personalized advice through trusted, local agents."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT